Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Siddharth Chauhan

Houston, TX Medical Doctor

NPI 1942799705 CMS profile 11550198

6431 Fannin St # 1.150, Ste 1, Houston, TX 77030

Open in the dashboard

General payments

$36,721

194 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Siddharth Chauhan of Houston, TX is reported in the CMS Open Payments database as having received $36,721 across 194 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,405 114
2024 General $23,832 50
2023 General $2,444 28
2021 General $41 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Siddharth Chauhan
  • Texas median
  • Middle half of Texas
  • National median

In program year 2025, general payments to Siddharth Chauhan were reported at $10,405. Among 86,592 Texas profiles paid that year, the median was $188 and the middle half received between $55 and $669.

Show as a table
Year Siddharth Chauhan Texas median Middle half National median
2019 $0 $191 $56–$744 $163
2020 $0 $125 $38–$452 $114
2021 $41 $150 $43–$543 $132
2022 $0 $169 $50–$606 $149
2023 $2,444 $183 $53–$639 $160
2024 $23,832 $188 $55–$666 $164
2025 $10,405 $188 $55–$669 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $20,545 17 payments
  2. Abbott Laboratories $7,375 96 payments
  3. Boston Scientific Corporation $7,110 49 payments
  4. Biosense Webster, Inc. $1,211 20 payments
  5. Amgen Inc. $130 1 payment
  6. AngioDynamics, Inc. $125 1 payment
  7. Pfizer Inc. $106 5 payments
  8. Janssen Pharmaceuticals, Inc $38 2 payments
  9. Ethicon US, LLC $32 1 payment
  10. Lantheus Medical Imaging, Inc. $26 1 payment
  11. Other $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $18,500 1 payment
  2. Food and Beverage $9,623 162 payments
  3. Travel and Lodging $7,754 26 payments
  4. Education $844 5 payments
Products named General payments · program years 2021–2025
  1. FARAPULSE $2,594 7 payments
  2. ENSITE $2,536 22 payments
  3. CARDIOMEMS $1,627 19 payments
  4. EVERA MRI XT DR SURESCAN $1,274 4 payments
  5. Carto 3 $1,138 18 payments
  6. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $611 4 payments
  7. S-ICD System Magnet $566 3 payments
  8. ENSITE PRECISION $467 5 payments
  9. Micra $439 3 payments
  10. General - Therapies $342 2 payments
  11. Other $3,797 96 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

194 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record